Management of hyper & hypo thyroid conditions.
In hyperthyroidism, the primary objective of therapy is to reduce secretion of thyroid hormone, which can be accomplished in various ways. The stimulus to hypersecretion can be removed in some causes of hyperthyroidism; in others, hormone synthesis and release can be inhibited by drugs such as thioamides, adrenergic blocking agents, or possibly lithium or glucocorticoids. Radioactive iodine is indicated for primary therapy of uncomplicated hyperthyroidism due to Graves' disease in persons over 30 years of age (myxedema may be a complication) and for treatment of autonomous thyroid adenoma in patients who are not suitable candidates for surgery. Surgical ablation is preferred for some causes of hyperthyroidism but may induce postoperative hypothyroidism. Hypothyroidism due to thyroid failure usually presents few therapeutic difficulties and can be managed simply by long-term hormone replacement. Before hormone replacement is prescribed for secondary or tertiary hypothyroidism, the other pituitary functions should be assessed.
D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000209:etiology / Q000628:therapy*; D007037:Hypothyroidism / Q000628:therapy*; D007455:Iodine / Q000627:therapeutic use; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013854:Thioamides / Q000627:therapeutic use; D013958:Thyroid Crisis / Q000628:therapy; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use
D013956:Antithyroid Agents; D005938:Glucocorticoids; D007457:Iodine Radioisotopes; D013854:Thioamides; D007455:Iodine; D008094:Lithium; D011433:Propranolol; D013974:Thyroxine